This site is intended for healthcare professionals only

Cancer Drugs Fund 'a huge waste of money'

Written by: | Published:

£1.72 billion was spent since 2010 £1.72 billion was spent since 2010

The Cancer Drugs Fund (CDF), which puts money aside to pay for expensive medicines the NHS could not usually afford, has been labelled a ‘huge waste of money’ in a leader cancer journal.

Annals of Oncology – a journal specialising in cancer –found the fund paid £1.27 billion between 2010 and 2016, which could have paid for an entire year of mainstream cancer drugs for the NHS. This followed a government promise to pay for cancer drugs the NHS was not funding, but it was found only one in five of the treatments the fund financed had been of benefit.

It ran separately to NICE from its inception in 2010 and was set up as a response to public outcry when cancer drugs were rejected by NICE for not being cost effective. It has since been brought under the control of NICE, who now use the fund to pay for treatments it feels there is a case to finance.

The Annals of Oncology article concluded: ‘The CDF has not delivered meaningful value to patients or society. There is no empirical evidence to support a ‘drug only’ ring fenced cancer fund relative to concomitant investments in other cancer domains such as surgery and radiotherapy, or other non-cancer medicines.

‘Reimbursement decisions for all drugs and interventions within cancer care should be made through appropriate health technology appraisal processes.’

Dr Ajay Aggarwal and colleagues, who authored the piece, found only 18% of drugs financed by the fund met international criteria for clinically benefit. They concluded that a majority of patients may have suffered because of side effects the drugs caused, possibly including from loss, upset stomachs and swelling in joints to an increased risk of stroke.

Where there was some evidence of benefit, the average was an extra 3.2 months of survival.

Emlyn Samuel, of Cancer Research UK, told the BBC he agreed with the researchers that the fund ‘wasn’t fit for purpose’. He said the charity would be closely monitoring the impact of the new system administered by NICE.

What do you think? Leave a comment below or tweet your views to @IndyNurseMag

This material is protected by MA Healthcare Ltd copyright.
See Terms and Conditions.

Comments

Name
 
Email
 
Comments
 

Please view our Terms and Conditions before leaving a comment.

Change the CAPTCHA codeSpeak the CAPTCHA code
 

Most read articles from Practice Nursing Journal

Practice Nursing Journal latest issue and most read articles.

Click here to read a selection of free to access articles from Practice Nursing Journal

Newsletter

Sign up to the newsletter

About

Independent Nurse is the professional resource for primary care and community nurses, providing clinical articles for practice nurses and prescribers.

Newsletter

Subscribe to our newsletter and stay up to date with the latest nursing news.

Stay Connected

Stay social with Independent Nurse by following us on Twitter, liking us on Facebook or connecting on LinkedIn.

Archive

Need access to some of our older articles? You can view our archive, or alternatively contact us.

Contact Us

MA Healthcare Ltd.
St Jude's Church, Dulwich Road
London, SE24 0PB

Tel: +44 (0)20 7738 5454
Registered in England and Wales No. 01878373

Meet the team

Authors

Find out how to contribute to Independent Nurse here.